Literature DB >> 12412760

Immunosuppression with cyclosporin A alters the thymic microenvironment.

M Kanariou1, R Huby, H Ladyman, M Colic, G Sivolapenko, I Lampert, M Ritter.   

Abstract

The effect of cyclosporin A (CyA) immunosuppression on the murine thymic microenvironment and T lymphocyte development has been analysed using monoclonal antibodies to epithelial and lymphocyte subpopulations, macrophages and major histocompatibility complex (MHC) class II antigens in immunohistochemistry and flow cytometry. The major microenvironmental target for CyA-induced damage was the thymic medulla, where a reduction in all epithelial cell subsets, dendritic cells and macrophages was observed. In contrast, the thymic cortex appeared essentially normal. CyA had no detectable effect on the intensity of microenvironmental expression of MHC class II molecules in either cortex or medulla, although the number of MHC class II positive medullary cells was reduced after CyA treatment. CyA also had a differential effect on the thymic lymphocyte populations where there was little change in the Thy-1 bright, CD5 dull, CD4+, CD8+ cortical thymocytes but a depletion of the Thy-1 dull, CD5 bright, CD4 or CD8 single-positive medullary cells. This lymphocyte loss may be due partly to increased migration from thymus to spleen and other peripheral lymphoid organs, and partly to a block in the differentiation stage from cortical to medullary lymphocyte. The thymic microenvironment and lymphocyte subpopulations recover rapidly after cessation of CyA treatment, although there may be longer term functional defects resulting from the CyA-induced injury.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 12412760      PMCID: PMC1534650     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Biological effects of cyclosporin A: a new antilymphocytic agent.

Authors:  J F Borel; C Feurer; H U Gubler; H Stähelin
Journal:  Agents Actions       Date:  1976-07

2.  Importance of IL-2 receptors in intra-thymic generation of cells expressing T-cell receptors.

Authors:  E J Jenkinson; R Kingston; J J Owen
Journal:  Nature       Date:  1987 Sep 10-16       Impact factor: 49.962

3.  Stimulatory effects of cyclosporin A on human and mouse thymic epithelial cells.

Authors:  M Dardenne; W Savino; G Feutren; J F Bach
Journal:  Eur J Immunol       Date:  1987-02       Impact factor: 5.532

4.  Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells.

Authors:  S Berrih; F Arenzana-Seisdedos; S Cohen; R Devos; D Charron; J L Virelizier
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

5.  Differential regulation of colony-stimulating factors and interleukin 2 production by cyclosporin A.

Authors:  M Bickel; H Tsuda; P Amstad; V Evequoz; S E Mergenhagen; S M Wahl; D H Pluznik
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Cyclosporin A and the thymus. Immunopathology.

Authors:  W E Beschorner; J D Namnoum; A D Hess; C A Shinn; G W Santos
Journal:  Am J Pathol       Date:  1987-03       Impact factor: 4.307

7.  Immune responses to organ allografts. III. Marked decrease in medullary thymocytes and splenic T lymphocytes after cyclosporin A treatment.

Authors:  W M Baldwin; I F Hutchinson; C J Meijer; N L Tilney
Journal:  Transplantation       Date:  1981-02       Impact factor: 4.939

8.  Co-expression of CD4 and CD8 molecules and de novo expression of MHC class II antigens on activated rat T cells.

Authors:  D J Bevan; P M Chisholm
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

9.  Cyclosporine-induced autoimmunity. Conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats.

Authors:  R Sorokin; H Kimura; K Schroder; D H Wilson; D B Wilson
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

10.  Essential role of the interleukin 2-interleukin 2 receptor pathway in thymocyte maturation in vivo.

Authors:  L Tentori; D L Longo; J C Zuñiga-Pflucker; C Wing; A M Kruisbeek
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  9 in total

1.  Heterogeneity of thymic epithelial cells in promoting T-lymphocyte differentiation in vivo.

Authors:  J C Gutierrez; R Palacios
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

2.  Developmental changes predispose the fetal thymus to positive selection of CD4+CD8- T cells.

Authors:  P J Fairchild; J M Austyn
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

Review 3.  The cyclosporins.

Authors:  Z Rehácek
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

4.  Selection of antibodies to cell surface determinants on mouse thymic epithelial cells using a phage display library.

Authors:  D B Palmer; A J George; M A Ritter
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

5.  The influence of FK-506 on the thymus: an immunophenotypic and structural analysis.

Authors:  R G Pugh-Humphreys; C S Ross; A W Thomson
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

6.  The effects of pregnancy on the mouse thymic epithelium.

Authors:  A G Clarke; A L Gil; M D Kendall
Journal:  Cell Tissue Res       Date:  1994-02       Impact factor: 5.249

7.  Studies on the thymus of non-obese diabetic (NOD) mice: effect of transgene expression.

Authors:  L A O'Reilly; D Healey; E Simpson; P Chandler; T Lund; M A Ritter; A Cooke
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

8.  Growth of epithelial cells in the thymic medulla is under the control of mature T cells.

Authors:  C D Surh; B Ernst; J Sprent
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

9.  Failures in thymus medulla regeneration during immune recovery cause tolerance loss and prime recipients for auto-GVHD.

Authors:  Abdullah S Alawam; Emilie J Cosway; Kieran D James; Beth Lucas; Andrea Bacon; Sonia M Parnell; Andrea J White; William E Jenkinson; Graham Anderson
Journal:  J Exp Med       Date:  2021-12-15       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.